Israel Practice

Latham’s Israel Practice helps clients navigate multijurisdictional deals and complex regulatory matters at the forefront of one of the world’s most innovative and dynamic markets.

With a presence in Israel and major commercial hubs around the globe, we advise on inbound and outbound transactions across industries, including high-tech, life sciences, and oil and gas. 

We advise public and private companies on Israel-related and international matters, as well as investment banks, government entities, private equity firms, and other investors. Our global interdisciplinary team, which also includes Israeli nationals who speak fluent Hebrew, offers multinational corporations active in Israel keen commercial and cultural insights on capital markets, M&A, regulatory, intellectual property, and venture capital matters. We work with a diverse mix of Israeli accelerators and corporations at every stage of the corporate life cycle, providing access to an international network of investor relationships, and sophisticated counsel that draws on one of the world’s largest private equity practices, trailblazing IPO experience, and a formidable track record in high-stakes M&A. 

Latham also helps Israeli clients commercialize and export technologies in compliance with international regulations — unlocking their full business potential. We help clients untangle the nuances of international regulations with practical, industry-savvy guidance and trial skills. Latham draws on significant experience advising Israeli life sciences companies on clinical trial strategy and compliance, US Center for Medicare and Medicaid Services (CMS) (coverage, coding, and payment), US Federal Drug Administration (FDA), US fraud and abuse compliance, US Health Insurance Portability and Accountability Act (HIPAA), and European data privacy protection.

Our notable work in Israel across practices includes advising: 

Capital Markets
Finance
  • The lender in connection with a term loan facility for Delek Drilling, an Israel-based partnership in the exploration, development, and production of natural gas and oil
  • The lender in connection with Project Alpha Intermediate Holding’s amended term loan facility in order to finance the acquisition of Attunity, an Israel-based seller of data integration and big data management software solutions
  • The lender in connection with an amended term loan facility for Crown Finance US, a movie theater operator, and subsidiary of UK-based Cineworld
  • The lender in connection with a term loan and revolving credit facility enabling BC Partners and Public Sector Pension Investment Board to acquire a majority stake in Keter Plastics, an Israeli manufacturer of plastic consumer products 
M&A
  • 888 Holdings in its £2.2 billion acquisition of non-US assets of William Hill, a UK-based company offering gaming, betting, online casino and poker sites.
  • Mellanox Technologies, an Israeli-American multinational chipmaker, in its US$6.9 billion sale to US technology giant NVIDIA Corporation — marking the second-largest-ever Israeli high-tech acquisition
  • Chevron North Sea Limited, a UK-based oil and gas exploration company, in its US$2 billion sale to Ithaca Energy Limited, a subsidiary of a leading Israeli energy company
  • Caesars Entertainment in its US$4.4 billion sale of Playtika, an Israel-based developer of casino-style and strategy games for social network play, to a consortium of investors led by Shanghai Giant Network Technology Co.
  • Ribbon Communications, a US-based communication software company, in its US$324 million acquisition of ECI Telecom Group, an Israel-based global provider of ELASTIC network solutions to service providers, critical industries, and data center operators
  • EPD Solutions, a British Virgin Islands-based manufacturer of image-guided medical devices for procedures on cardiac arrhythmias, in its €250 million sale to Royal Philips 
Private Equity
Emerging Companies
  • Trax Technology Solutions, a Singapore-headquartered provider of computer vision and analytics solutions for retail, in its US$125 million investment round led Boyu Capital, one of the largest private equity investment firms in Greater China
  • Selina, a Panama-based company engaged in providing accommodation and lodging facilities for travelers, on its US$125 million Series C Financing
  • Sapphire Ventures, a Silicon Valley-based venture capital company, in its US$150 million equity investment in Monday.com, a Tel Aviv-based workplace collaboration platform
  • Hippo, an insurtech company providing home insurance products, on its US$170 million Series E Financing and Common Stock Offering
Intellectual Property and Regulatory
  • DreaMed, an Israel-headquartered medical device and SaaS company, on its Medicare reimbursement strategy
  • Itamar Medical, an Israel-headquartered medical technology company, on its Medicare and commercial payer reimbursement strategies
  • Various Israeli pharmaceutical and biotechnology companies, including Dexcel Pharma, Mediwound, and Sol-Gel Technologies, on FDA regulatory matters
Awards & Rankings content for Israel Practice
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.